Cytori Therapeutics, Inc. (CYTX)

[JJAAMMAANN]

Great News! Loan Payments Deferred! More Money to R&D

http://ih.advfn.com/p.php?pid=nmona&article=70512587

On February 23, 2016, Cytori Therapeutics, Inc. (the "Company") received an acknowledgement and agreement from Oxford Finance LLC, as collateral agent and lender ("Oxford") that Oxford had received evidence, in form and substance reasonably satisfactory to Oxford, that the Company had received positive data on its US ACT-OA clinical trial. As a result, pursuant to the Loan and Security Agreement (the "Loan Agreement"), dated May 29, 2015, with Oxford and the other lenders party thereto from time to time, the period for which the Company is only required to make interest-only payment was extended from June 1, 2016 to January 1, 2017 (the "Amortization Commencement Date"). Following the Amortization Commencement Date, the Company is required to make payments of principal and accrued interest in equal monthly installments sufficient to amortize the Term Loan through June 1, 2019, the maturity date.